Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Ivonescimab plus gemcitabine and cisplatin as first-line therapy for advanced biliary tract cancer: a multicenter, open-label phase 2 trial.

Journal of hepatology·2026

Same author

Tailoring the Electron-Enriched Microenvironment of UiO-66 via Thiol Functionalization to Boost Non-Thermal Plasma CO<sub>2</sub> Conversion.

Inorganic chemistry·2026

Same author

Trend of fishery carbon sink in Chinese bivalve aquaculture from 2004 to 2023.

Carbon balance and management·2026

Same author

Unraveling the complex role of intestinal microbiota in drug permeability: Insights from N-acetylcysteine.

Asian journal of pharmaceutical sciences·2026

Same author

Magnetoelectric microrobots for spinal cord injury regeneration.

Nature materials·2026

Same author

A preoperative ultrasound-based radiomics-clinical nomogram to assess metastasis of ipsilateral supraclavicular lymph nodes in patients with primary breast cancer: A biomarker based on breast and axillary images.

Surgical oncology·2026

Same journal

Copper metallodendrimers effectively deliver proapoptotic siRNA to human liver carcinoma HepG2 cells.

International journal of pharmaceutics·2026

Same journal

A styrene-maleic acid copolymer-based boron carrier for tumor-retentive boron delivery in boron neutron capture therapy.

International journal of pharmaceutics·2026

Same journal

Programmable gene modulation networks for Parkinson's disease using nanotechnology enabled CRISPR/Cas brain delivery.

International journal of pharmaceutics·2026

Same journal

Dual carboxylic ionization driven MCC/MAA/IA hydrogels for enhanced oral insulin delivery.

International journal of pharmaceutics·2026

Same journal

Artificial intelligence and CRISPR-based approaches for targeted delivery of bacteriophages.

International journal of pharmaceutics·2026

Same journal

A "three-in-one" nose-to-brain delivery strategy: intranasal vancomycin spray achieves simultaneous clearance of pneumococcal colonization, bacteremia, and meningitis.

International journal of pharmaceutics·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Sep 10, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Self-amplifying ROS-responsive trinity nanodelivery system for enhanced cancer therapy.

Jia Deng¹, Na Liu¹, Haina Zhao¹

¹Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.

International Journal of Pharmaceutics

|August 21, 2025

Summary

This summary is machine-generated.

This study presents a novel nanodelivery system that triggers ferroptosis (a form of cell death) in tumors by combining iron overload, antioxidant inhibition, and substrate supply for amplified cancer cell death.

Keywords:

Ferroptosis Nano-assembly Polyunsaturated fatty acids RSL3 Tumor-on-a-chip

More Related Videos

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

Related Experiment Videos

Last Updated: Sep 10, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

Area of Science:

Biomedical Engineering
Nanotechnology
Cancer Therapy

Background:

Ferroptosis is a promising antitumor strategy but faces challenges like toxicity and poor specificity.
Existing ferroptosis inducers often target single pathways, limiting efficacy.

Purpose of the Study:

To develop a novel reactive oxygen species (ROS)-responsive nanodelivery system for enhanced ferroptosis induction.
To overcome limitations of conventional ferroptosis inducers through a multi-pronged approach.

Main Methods:

Co-assembly of Ferrocenecarboxaldehyde (Fc-CHO) and RAS-selective lethal 3 (RSL3) into nanostructures with AA-PEG2k.
Utilizing the tumor microenvironment to trigger ROS burst via Fenton reaction.
ROS-mediated cleavage of AA-PEG2k to release RSL3, inhibiting GPX4 and supplying arachidonic acid (AA) for lipid peroxidation.

Main Results:

The nanodelivery system achieved cascade amplification of ferroptosis.
Demonstrated significant antitumor efficacy in vitro (tumor-on-a-chip) and in vivo animal studies.
Successfully overcame ferroptosis resistance through integrated pathway regulation.

Conclusions:

The developed trinity nanodelivery system offers a versatile strategy for precise ferroptosis induction.
Provides a theoretical foundation for developing targeted nanomaterials in cancer therapy.
Highlights the potential of multi-pathway targeting for overcoming drug resistance.